To corroborate the therapeutic potential of DUBTACs, Jin, Wei, and co-workers established a platform of DUBTACs for different transcription factors (p53, FOXO3A, and IRF3) which function as tumor suppressors [61]. The gene discussed is TP53; the disease is neoplasm.